These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 8808167

  • 1. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR, Faulds D.
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [Abstract] [Full Text] [Related]

  • 2. Ebastine: an update of its use in allergic disorders.
    Hurst M, Spencer CM.
    Drugs; 2000 Apr; 59(4):981-1006. PubMed ID: 10804044
    [Abstract] [Full Text] [Related]

  • 3. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J.
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [Abstract] [Full Text] [Related]

  • 4. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
    Van Cauwenberge P, De Belder T, Sys L.
    Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
    [Abstract] [Full Text] [Related]

  • 5. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
    Kalis B.
    Drugs; 1996 Aug; 52 Suppl 1():30-4. PubMed ID: 8828024
    [Abstract] [Full Text] [Related]

  • 6. Antihistamines in severe/chronic rhinitis.
    Bousquet J.
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():49-53. PubMed ID: 9988436
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
    Yakuo I, Ishii K, Seto Y, Imano K, Takeyama K, Nakamura H, Karasawa T.
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
    Ratner PH, Lim JC, Georges GC.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA, del Prado M, Sherwood J, Kreutner W, Egan RW.
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [Abstract] [Full Text] [Related]

  • 11. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P, Bremard-Oury C, Zeisser P.
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [Abstract] [Full Text] [Related]

  • 12. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
    Frossard N, Benabdesselam O, Purohit A, Mounedji N, Pauli G.
    Fundam Clin Pharmacol; 2000 Jun; 14(4):409-13. PubMed ID: 11030449
    [Abstract] [Full Text] [Related]

  • 13. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
    Storms WW.
    Drugs; 1996 Jun; 52 Suppl 1():20-5. PubMed ID: 8828022
    [Abstract] [Full Text] [Related]

  • 14. Ebastine in perennial allergic rhinitis.
    Picado Vallés C, Cadahia García A, Cisteró Bahima A, Cano Cantudo L, Sanz Amaro A, Zayas Sanza JM.
    Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
    Bousquet J, Gaudaño EM, Palma Carlos AG, Staudinger H.
    Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA, Riethuisen JM, Moulaert B, DeVos C.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [Abstract] [Full Text] [Related]

  • 18. Comparative clinical studies with ebastine: efficacy and tolerability.
    Luria X.
    Drug Saf; 1999 Feb; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis.
    Peláez A.
    Drugs; 1996 Feb; 52 Suppl 1():35-8. PubMed ID: 8828025
    [Abstract] [Full Text] [Related]

  • 20. Ebastine in the Treatment of Allergic Rhinitis and Urticaria: 30 Years of Clinical Studies and Real-World Experience.
    Sastre J.
    J Investig Allergol Clin Immunol; 2020 Feb; 30(3):156-168. PubMed ID: 30977465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.